Funding
Funding not disclosed
Founders
Product
Problem
Current cancer treatments often have significant side effects and limited efficacy, highlighting the need for more targeted and effective therapies. Existing diagnostic tools may also lack the sensitivity and specificity required for early and accurate detection of malignant diseases.
Solution
IBMsol develops bio-plasma technology-based medical devices designed to target and treat malignant diseases while enhancing diagnostic capabilities. Their solutions aim to provide more effective anti-cancer treatments with potentially fewer side effects compared to traditional methods. By leveraging bio-plasma technology, IBMsol seeks to improve the precision and accuracy of disease detection, leading to better patient outcomes and enhanced oncology care.
Target Audience
The primary target audience includes oncologists, hospitals, and medical research institutions seeking advanced tools for cancer treatment and diagnostics.
Features
- Bio-plasma technology for targeted cancer treatment
- Medical devices designed for enhanced diagnostic environments